Log In
Print this Print this

REMD-477 (formerly AMG 477)

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionHuman mAb glucagon receptor (GCGR) antagonist
Molecular Target Glucagon receptor (GCGR)
Mechanism of ActionGlucagon receptor antagonist; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes; Treat Type I diabetes
Regulatory Designation
PartnerRemd Biotherapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today